FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236135868> ?p ?o ?g. }

• W4236135868 endingPage "23" @default.
• W4236135868 startingPage "23" @default.
• W4236135868 abstract "<ns4:p><ns4:bold>Background</ns4:bold>: Funding for neglected disease product development fell from 2009-2015, other than a brief injection of Ebola funding. One impediment to mobilizing resources is a lack of information on product candidates, the estimated costs to move them through the pipeline, and the likelihood of specific launches. This study aimed to help fill these information gaps.</ns4:p><ns4:p> <ns4:bold>Methods</ns4:bold>: We conducted a pipeline portfolio review to identify current candidates for 35 neglected diseases. Using an adapted version of the Portfolio to Impact financial modelling tool, we estimated the costs to move these candidates through the pipeline over the next decade and the likely launches. Since the current pipeline is unlikely to yield several critical products, we estimated the costs to develop a set of priority “missing” products.</ns4:p><ns4:p> <ns4:bold>Results: </ns4:bold>We found 685 neglected disease product candidates as of August 31, 2017; 538 candidates met inclusion criteria for input into the model. It would cost about $16.3 billion (range $13.4-19.8B) to move these candidates through the pipeline, with three-quarters of the costs incurred in the first 5 years, resulting in about 128 (89-160) expected product launches. Based on the current pipeline, there would be few launches of complex new chemical entities; launches of highly efficacious HIV, tuberculosis, or malaria vaccines would be unlikely. Estimated additional costs to launch one of each of 18 key missing products are $13.6B assuming lowest product complexity or $21.8B assuming highest complexity ($8.1B-36.6B). Over the next 5 years, total estimated costs to move current candidates through the pipeline and develop these 18 missing products would be around $4.5B (low complexity missing products) or $5.8B/year (high complexity missing products).</ns4:p><ns4:p> <ns4:bold>Conclusions</ns4:bold>: Since current annual global spending on product development is about $3B, this study suggests the annual funding gap over the next 5 years is at least $1.5-2.8B.</ns4:p>" @default.
• W4236135868 created "2022-05-12" @default.
• W4236135868 creator A5008500261 @default.
• W4236135868 creator A5009442108 @default.
• W4236135868 creator A5011388011 @default.
• W4236135868 creator A5026198439 @default.
• W4236135868 creator A5030516982 @default.
• W4236135868 creator A5031461286 @default.
• W4236135868 creator A5049886353 @default.
• W4236135868 creator A5052343273 @default.
• W4236135868 creator A5056778092 @default.
• W4236135868 creator A5064946658 @default.
• W4236135868 creator A5067994314 @default.
• W4236135868 creator A5077510286 @default.
• W4236135868 creator A5082094092 @default.
• W4236135868 creator A5084318732 @default.
• W4236135868 creator A5084382216 @default.
• W4236135868 creator A5085601003 @default.
• W4236135868 date "2020-02-19" @default.
• W4236135868 modified "2023-09-28" @default.
• W4236135868 title "Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model" @default.
• W4236135868 cites W1485822442 @default.
• W4236135868 cites W1997362383 @default.
• W4236135868 cites W1998352399 @default.
• W4236135868 cites W2021058078 @default.
• W4236135868 cites W2098679935 @default.
• W4236135868 cites W2130131759 @default.
• W4236135868 cites W2166550586 @default.
• W4236135868 cites W2192837316 @default.
• W4236135868 cites W2263331096 @default.
• W4236135868 cites W2273267066 @default.
• W4236135868 cites W2297119734 @default.
• W4236135868 cites W2402631208 @default.
• W4236135868 cites W2496051869 @default.
• W4236135868 cites W2751884637 @default.
• W4236135868 cites W2794213969 @default.
• W4236135868 cites W2802767235 @default.
• W4236135868 cites W4245728364 @default.
• W4236135868 cites W4320288076 @default.
• W4236135868 doi "https://doi.org/10.12688/gatesopenres.12817.3" @default.
• W4236135868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30234193" @default.
• W4236135868 hasPublicationYear "2020" @default.
• W4236135868 type Work @default.
• W4236135868 citedByCount "13" @default.
• W4236135868 countsByYear W42361358682019 @default.
• W4236135868 countsByYear W42361358682020 @default.
• W4236135868 countsByYear W42361358682021 @default.
• W4236135868 countsByYear W42361358682022 @default.
• W4236135868 countsByYear W42361358682023 @default.
• W4236135868 crossrefType "journal-article" @default.
• W4236135868 hasAuthorship W4236135868A5008500261 @default.
• W4236135868 hasAuthorship W4236135868A5009442108 @default.
• W4236135868 hasAuthorship W4236135868A5011388011 @default.
• W4236135868 hasAuthorship W4236135868A5026198439 @default.
• W4236135868 hasAuthorship W4236135868A5030516982 @default.
• W4236135868 hasAuthorship W4236135868A5031461286 @default.
• W4236135868 hasAuthorship W4236135868A5049886353 @default.
• W4236135868 hasAuthorship W4236135868A5052343273 @default.
• W4236135868 hasAuthorship W4236135868A5056778092 @default.
• W4236135868 hasAuthorship W4236135868A5064946658 @default.
• W4236135868 hasAuthorship W4236135868A5067994314 @default.
• W4236135868 hasAuthorship W4236135868A5077510286 @default.
• W4236135868 hasAuthorship W4236135868A5082094092 @default.
• W4236135868 hasAuthorship W4236135868A5084318732 @default.
• W4236135868 hasAuthorship W4236135868A5084382216 @default.
• W4236135868 hasAuthorship W4236135868A5085601003 @default.
• W4236135868 hasBestOaLocation W42361358681 @default.
• W4236135868 hasConcept C10138342 @default.
• W4236135868 hasConcept C127413603 @default.
• W4236135868 hasConcept C144133560 @default.
• W4236135868 hasConcept C2524010 @default.
• W4236135868 hasConcept C2780821815 @default.
• W4236135868 hasConcept C33923547 @default.
• W4236135868 hasConcept C43521106 @default.
• W4236135868 hasConcept C78519656 @default.
• W4236135868 hasConcept C90673727 @default.
• W4236135868 hasConceptScore W4236135868C10138342 @default.
• W4236135868 hasConceptScore W4236135868C127413603 @default.
• W4236135868 hasConceptScore W4236135868C144133560 @default.
• W4236135868 hasConceptScore W4236135868C2524010 @default.
• W4236135868 hasConceptScore W4236135868C2780821815 @default.
• W4236135868 hasConceptScore W4236135868C33923547 @default.
• W4236135868 hasConceptScore W4236135868C43521106 @default.
• W4236135868 hasConceptScore W4236135868C78519656 @default.
• W4236135868 hasConceptScore W4236135868C90673727 @default.
• W4236135868 hasFunder F4320306137 @default.
• W4236135868 hasLocation W42361358681 @default.
• W4236135868 hasLocation W42361358682 @default.
• W4236135868 hasLocation W42361358683 @default.
• W4236135868 hasLocation W42361358684 @default.
• W4236135868 hasOpenAccess W4236135868 @default.
• W4236135868 hasPrimaryLocation W42361358681 @default.
• W4236135868 hasRelatedWork W17432683 @default.
• W4236135868 hasRelatedWork W18200074 @default.
• W4236135868 hasRelatedWork W19811004 @default.
• W4236135868 hasRelatedWork W20997033 @default.
• W4236135868 hasRelatedWork W21590378 @default.
• W4236135868 hasRelatedWork W35811808 @default.

• next